Rich Stuart
Chief Medical Officer
Rich Stuart has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Dec 10, 2025.
On the most recent filing, Rich Stuart is listed as Chief Medical Officer at TENAX THERAPEUTICS, INC. Inside the rolling window, Rich Stuart reported 5 open-market purchases totaling $96K in TENX and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,500 TENX shares on Dec 9, 2025, worth $26K.
Companies traded
Other insiders at TENX
Insider Buying
$96K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rich Stuart made?
Rich Stuart has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Rich Stuart trade?
Rich Stuart has filed SEC Form 4 disclosures for 1 company, including TENX.
When was Rich Stuart's most recent SEC Form 4 filing?
Rich Stuart's most recent SEC Form 4 filing on Tracefour is dated Dec 10, 2025.
What is Rich Stuart's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rich Stuart is listed as Chief Medical Officer.
What is Rich Stuart's total buy and sell value in the current window?
Inside the rolling retention window, Rich Stuart bought $96K and sold $0 based on SEC Form 4 filings.
What was Rich Stuart's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,500 TENX shares on 2025-12-09, worth $26K, per SEC Form 4 filings.